These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6371881

  • 1. Converting-enzyme inhibition and 1-sarcosine-8-isoleucine-angiotensin II: effects on renal function in the dehydrated sheep.
    Yesberg NE, Henderson M, Dallemagne C, Law S, Hamilton D, Cross RB.
    Q J Exp Physiol; 1984 Jan; 69(1):133-43. PubMed ID: 6371881
    [Abstract] [Full Text] [Related]

  • 2. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH, Anderson WP, Johnston CI.
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [Abstract] [Full Text] [Related]

  • 3. Renal response to pentobarbital anesthesia in rats: effect of interrupting the renin-angiotensin system.
    Walker LA, Gellai M, Valtin H.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):721-8. PubMed ID: 3512818
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.
    Clark KL, Robertson MJ, Drew GM.
    Br J Pharmacol; 1993 May; 109(1):148-56. PubMed ID: 8495237
    [Abstract] [Full Text] [Related]

  • 6. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A.
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun 20; 56(6):868-83. PubMed ID: 6997093
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
    Heller J, Kramer HJ, Horácek V.
    Kidney Blood Press Res; 1997 Jun 20; 20(6):391-7. PubMed ID: 9453450
    [Abstract] [Full Text] [Related]

  • 8. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N, Khang S, Wead LM, Blantz RC, Gabbai FB.
    Am J Kidney Dis; 2002 Jan 20; 39(1):159-64. PubMed ID: 11774115
    [Abstract] [Full Text] [Related]

  • 9. The effects of a converting enzyme inhibitor (captopril) and angiotensin II on fetal renal function.
    Lumbers ER, Burrell JH, Menzies RI, Stevens AD.
    Br J Pharmacol; 1993 Oct 20; 110(2):821-7. PubMed ID: 8242257
    [Abstract] [Full Text] [Related]

  • 10. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE, Gillespie JB.
    Fed Proc; 1984 Apr 20; 43(5):1336-41. PubMed ID: 6323226
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypotensive response to angiotensin II analogue and angiotensin I converting enzyme inhibitor in pseudo-Bartter's syndrome.
    Sasaki H, Kawasaki T, Fujisawa M, Motooka Y, Asano T, Okumura M.
    Jpn Heart J; 1981 Jul 20; 22(4):689-93. PubMed ID: 6272003
    [Abstract] [Full Text] [Related]

  • 13. Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.
    Forhead AJ, Whybrew K, Hughes P, Broughton Pipkin F, Sutherland M, Fowden AL.
    Br J Pharmacol; 1996 Sep 20; 119(2):393-401. PubMed ID: 8886426
    [Abstract] [Full Text] [Related]

  • 14. Changes in the maternal and fetal renin-angiotensin systems in response to angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.
    Forhead AJ, Broughton Pipkin F, Sutherland MF, Fowden AL.
    Exp Physiol; 1997 Jul 20; 82(4):761-76. PubMed ID: 9257117
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the mechanism of acute decrease of blood pressure induced by captopril (SQ 14,225) in dogs by the use of aprotinin, SAR1-ILE8-angiotensin II and indomethacin.
    Ohara N, Ono H, Hashimoto K.
    Jpn Circ J; 1981 Jun 20; 45(6):672-9. PubMed ID: 6165844
    [Abstract] [Full Text] [Related]

  • 16. Renal effects of angiotensin II inhibition during increases in renal venous pressure.
    Fiksen-Olsen MJ, Strick DM, Hawley H, Romero JC.
    Hypertension; 1992 Feb 20; 19(2 Suppl):II137-41. PubMed ID: 1735568
    [Abstract] [Full Text] [Related]

  • 17. Renal, adrenal and vascular changes during inhibition of converting enzyme with captopril.
    Clappison BH, Millar JA, Casley DJ, Anderson WP, Johnston CI.
    Clin Exp Pharmacol Physiol; 1980 Feb 20; 7(5):493-8. PubMed ID: 6256104
    [Abstract] [Full Text] [Related]

  • 18. Effects of converting enzyme inhibition with captopril on renal function in normal and ACTH treated sheep.
    Whitworth JA, Hammond TG, Stewart KW, Mason RT, Schneider EG, Denton DA, Coghlan JP, Scoggins BA.
    Clin Exp Pharmacol Physiol; 1982 Feb 20; 9(5):505-9. PubMed ID: 6291827
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
    Wong PC, Price WA, Reilly TM, Duncia JV, Timmermans PB.
    J Pharmacol Exp Ther; 1989 Aug 20; 250(2):515-22. PubMed ID: 2668502
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor.
    Robberecht W, Andries M, Denef C.
    Neuroendocrinology; 1992 Aug 20; 56(2):185-94. PubMed ID: 1407372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.